Elevated antimüllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome
- 6 July 2024
- journal article
- editorial
- Published by Elsevier in Fertility and Sterility
- Vol. 122 (4) , 633-634
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysisFertility and Sterility, 2024
- Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomesAmerican Journal of Obstetrics and Gynecology, 2014
- Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentFertility and Sterility, 2005
- Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cyclesFertility and Sterility, 2002